title: Effect of combined oral proteases and flavonoid treatment in subjects at risk of Type 1 diabetes.
authors.forename: K
authors.initials: K
authors.lastname: Kempf
authors.forename: G
authors.initials: G
authors.lastname: Manzo
authors.forename: P
authors.initials: P
authors.lastname: Hanifi-Moghaddam
authors.forename: S
authors.initials: S
authors.lastname: Kappler
authors.forename: J
authors.initials: J
authors.lastname: Seissler
authors.forename: C
authors.initials: C
authors.lastname: Jaeger
authors.forename: B
authors.initials: B
authors.lastname: Boehm
authors.forename: M
authors.initials: M
authors.lastname: Roden
authors.forename: H
authors.initials: H
authors.lastname: Kolb
authors.forename: S
authors.initials: S
authors.lastname: Martin
authors.forename: N C
authors.initials: NC
authors.lastname: Schloot
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001963:Bromelains / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D010919:Placebos; D011446:Prospective Studies; D012306:Risk; D012431:Rutin / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D016207:Cytokines; D005419:Flavonoids; D010919:Placebos; D012431:Rutin; D001963:Bromelains; D010447:Peptide Hydrolases; D014357:Trypsin